V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210000349 | 210012602 | 1.63 | 76.1 | Palliative (P) | 2020-03-09 | 2020-03-24 | Trial Unspecified | 02 | N | PALBOCICLIB | 100771838 |
| 210000406 | 210012603 | 1.73 | 93 | Palliative (P) | 2021-07-19 | 2021-11-03 | Capecitabine | 02 | N | CAPECITABINE | 101185927 |
| 210000892 | 210012606 | 1.69 | 80 | Adjuvant (A) | 2017-04-23 | 2017-05-07 | R GCVP | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100248794 |
| 210001086 | 210012608 | 1.68 | 88 | null | 2019-08-23 | 2019-08-31 | null | null | null | TRASTUZUMAB EMTANSINE | 101663547 |
| 210001120 | 210012610 | 1.62 | 59.6 | null | null | 2020-01-24 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100823922 |
| 210001126 | 210012611 | 1.75 | 78 | Adjuvant (A) | 2020-02-22 | 2020-02-29 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101674658 |
| 210001184 | 210012612 | 1.61 | 99.4 | null | 2016-03-08 | 2017-09-29 | Cyclophosphamide+Doce+Tras Main | null | null | LETROZOLE + PALBOCICLIB | 100896768 |
| 210001402 | 210012614 | 1.74 | 83.5 | Palliative (P) | 2022-04-20 | 2022-04-30 | GEMCARBO | null | N | CARBOPLATIN + GEMCITABINE | 101758627 |
| 210001443 | 210012615 | 1.47 | 78.5 | null | 2017-10-12 | 2018-11-17 | Capecitabine | 02 | null | CAPECITABINE | 100966119 |
| 210001961 | 210012619 | 1.65 | 68.9 | null | 2020-09-12 | 2020-09-20 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101469850 |
| 210001963 | 210012620 | 1.72 | 91.6 | Palliative (P) | null | 2020-04-09 | ABEMACICLIB + FULVESTRANT | 02 | N | LETROZOLE + PALBOCICLIB | 101232145 |
| 210001994 | 210012621 | 1.61 | 72.2 | null | 2019-12-06 | 2019-12-16 | ABEMACICLIB + FULVESTRANT | 02 | null | LETROZOLE + PALBOCICLIB | 100155303 |
| 210002052 | 210012624 | 1.75 | 96 | null | 2021-01-28 | 2021-05-10 | ABEMACICLIB + FULVESTRANT | 02 | null | CARBOPLATIN + DOCETAXEL | 100843902 |
| 210002260 | 210012630 | null | null | Neo-adjuvant (N) | 2020-03-28 | 2020-04-13 | null | 02 | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101555067 |
| 210002431 | 210012633 | null | null | null | 2020-08-02 | 2020-11-30 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100024558 |
| 210002443 | 210012634 | 1.53 | 94.5 | null | 2018-08-12 | 2018-08-20 | null | null | null | PALBOCICLIB | 101261577 |
| 210002628 | 210012636 | null | 75 | null | 2018-08-25 | 2019-02-07 | Capecitabine | 02 | null | ROSCO TRIAL | 101416903 |
| 210002637 | 210012637 | 1.65 | 107 | null | 2021-01-26 | 2021-05-20 | null | 02 | null | PALBOCICLIB | 101493616 |
| 210002751 | 210012638 | 1.47 | 55.9 | null | 2019-04-15 | 2019-04-21 | Capecitabine | 01 | null | CAPECITABINE | 100755182 |
| 210002805 | 210012639 | 1.57 | 70.7 | null | 2017-04-08 | 2017-04-26 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | null | EC | 101615942 |
| 210002942 | 210012640 | null | 94.55 | Palliative (P) | 2020-10-09 | 2020-12-27 | Eribulin | null | N | ERIBULIN | 101053988 |
| 210003226 | 210012641 | null | 89.7 | Adjuvant (A) | 2020-07-19 | 2020-08-23 | Letrozole + Palbociclib | 02 | N | DOCETAXEL + TRASTUZUMAB | 100456723 |
| 210003249 | 210012642 | 1.57 | 88.4 | Neo-adjuvant (N) | 2019-03-21 | 2019-03-29 | Neratinib | 02 | N | NERATINIB | 100715933 |
| 210003252 | 210012643 | 1.55 | 93.2 | null | 2022-01-21 | 2022-01-28 | EVEROLIMUS | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101129757 |
| 210003439 | 210012645 | 1.61 | 71 | Adjuvant (A) | 2017-11-02 | 2017-11-24 | Paclitaxel+Trastuzumab wkly Maint | 01 | N | PACLITAXEL + TRASTUZUMAB | 100457558 |
| 210003476 | 210012648 | 1.57 | null | Palliative (P) | null | 2020-02-26 | Capecitabine | 02 | N | CAPECITABINE | 100010778 |
| 210003548 | 210012650 | 1.67 | 65.9 | null | 2019-09-01 | 2019-09-23 | null | 02 | null | PALBOCICLIB | 100525179 |
| 210003879 | 210012655 | null | 87.5 | null | null | 2021-06-18 | EC | null | null | EC | 100017528 |
| 210003221 | 210012836 | null | 0 | null | 2022-02-14 | 2022-03-21 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 100633312 |
| 210003225 | 210012839 | 1.6 | 66.4 | Palliative (P) | 2018-05-09 | 2018-07-18 | PACLITAXEL | 02 | N | PACLITAXEL | 101114576 |
| 210003228 | 210012840 | 1.59 | 108.5 | Adjuvant (A) | null | 2021-11-02 | PACLITAXEL | 02 | N | PACLITAXEL | 101095975 |
| 210003232 | 210012841 | 1.71 | 77.2 | Palliative (P) | 2020-08-15 | 2020-08-15 | Docetaxel | null | N | DOCETAXEL | 100731432 |
| 210003243 | 210012842 | 1.6 | 86.2 | Palliative (P) | null | 2021-09-14 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100106659 |
| 210003257 | 210012843 | null | 60.95 | null | 2021-01-03 | 2021-01-11 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101116878 |
| 210003261 | 210012844 | 1.5 | 65.2 | Adjuvant (A) | 2021-06-22 | 2021-07-07 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100518616 |
| 210003270 | 210012845 | 1.72 | null | Adjuvant (A) | null | 2018-01-12 | Trastuzumab 21 day maintenance | 02 | Y | TRASTUZUMAB | 100006670 |
| 210003277 | 210012848 | 1.71 | 57.5 | Adjuvant (A) | null | 2020-01-10 | Trastuzumab | 02 | N | TRASTUZUMAB | 100163578 |
| 210003278 | 210012849 | 1.71 | 67.6 | Adjuvant (A) | 2019-05-29 | 2019-06-12 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100603073 |
| 210003282 | 210012850 | 1.62 | 140.7 | Palliative (P) | null | 2021-10-09 | Docetaxel | 02 | N | DOCETAXEL | 100093197 |
| 210003284 | 210012852 | null | 75.75 | null | null | 2016-08-13 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101831786 |
| 210003295 | 210012854 | null | null | null | null | 2020-05-29 | Paclitaxel 7 day | null | null | PACLITAXEL | 101706298 |
| 210003300 | 210012857 | 1.63 | 76.65 | Adjuvant (A) | null | 2020-05-31 | Trastuzumab | 02 | N | TRASTUZUMAB | 100201936 |
| 210003302 | 210012858 | 1.65 | 61 | Palliative (P) | null | 2020-04-10 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100588109 |
| 210003309 | 210012859 | 1.77 | 60 | Adjuvant (A) | null | 2021-04-12 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100412354 |
| 210003312 | 210012860 | 1.64 | 91.7 | Adjuvant (A) | 2019-09-01 | 2019-12-07 | Trastuzumab | 02 | N | TRASTUZUMAB | 100032054 |
| 210003314 | 210012861 | 1.51 | null | Adjuvant (A) | null | 2020-10-18 | Docetaxel | null | N | DOCETAXEL | 100408927 |
| 210003319 | 210012862 | 1.54 | 62.7 | Adjuvant (A) | null | 2021-05-07 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100875292 |
| 210003325 | 210012863 | 1.64 | 56.5 | Adjuvant (A) | null | 2021-03-25 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100793026 |
| 210003326 | 210012864 | 1.57 | 93 | Neo-adjuvant (N) | 2022-01-24 | 2022-03-07 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101671812 |
| 210003328 | 210012865 | 1.61 | 52.8 | Adjuvant (A) | 2020-01-04 | 2020-01-05 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101346546 |